Romanian stock indices turn green, TTS shines
Ljubljana stock indices go down, Cinkarna Celje paces decliners
Romania’s Orsova shipyard in 2.6 mln euro deal with Dutch client
Serbia opens Morava Corridor motorway section - report
Croatia’s Ploce port authority, Markoja get EU funds for 5G project
Dec 20, 2007 18:17 EEST
December 20 (SeeNews) - Romania on Thursday set a starting price of 136 million euro ($195.067 million) for the sale of its 53.0173% stake in local drug maker Antibiotice, a government official said.
"We are making an open bid tender, starting at a price of 2.0 lei [$0.8156/0.5687 euro] per share, which means approximately 136 million euro for the entire stake," the head of the government's asset selling agency, AVAS, Teodor Atanasiu told a news conference.
You can subscribe to our M&A newsletter here
The open bidding tender is scheduled for March 18 next year, AVAS said in a statement.
(1 euro = 3.517 Romanian lei)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options